Вы находитесь на странице: 1из 19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

OfficialreprintfromUpToDate
www.uptodate.com2015UpToDate

Clinicalmanifestationsanddiagnosisofechinococcosis
Author
PedroLMoro,MD,MPH

SectionEditor
PeterFWeller,MD,FACP

DeputyEditor
ElinorLBaron,MD,DTMH

Alltopicsareupdatedasnewevidencebecomesavailableandourpeerreviewprocessiscomplete.
Literaturereviewcurrentthrough:Jan2015.|Thistopiclastupdated:Oct21,2014.
INTRODUCTIONEchinococcaldiseaseiscausedbyinfectionwiththemetacestodestageofthetapeworm
Echinococcus,whichbelongstothefamilyTaeniidae.FourspeciesofEchinococcusproduceinfectionin
humansE.granulosusandE.multilocularisarethemostcommon,causingcysticechinococcosis(CE)and
alveolarechinococcosis(AE),respectively.Thetwootherspecies,E.vogeliandE.oligarthrus,cause
polycysticechinococcosisbuthaveonlyrarelybeenassociatedwithhumaninfection.
Theclinicalmanifestationsanddiagnosisofcysticandalveolarechinococcalinfectionwillbereviewedhere.
Theepidemiology,treatment,andpreventionofechinococcosisarediscussedseparately.(See"Epidemiology
andcontrolofechinococcosis"and"Treatmentofechinococcosis".)
CLINICALMANIFESTATIONSTheEchinococcusspecieshavedifferentgeographicdistributionsand
involvedifferenthosts.E.granulosusandE.multilocularisalsodifferintheirclinicalpresentation.(See
"Epidemiologyandcontrolofechinococcosis".)
EchinococcusgranulosusTheinitialphaseofprimaryinfectionisalwaysasymptomatic.Manyinfections
areacquiredinchildhoodbutdonotcauseclinicalmanifestationsuntiladulthood.Latentperiodsofmorethan
50yearsbeforesymptomsarisehavebeenreported.Whileapproximately50percentofdetectedcasesoccur
inasymptomaticpatients,manymorecasesremainundiagnosedorarefoundincidentallyatautopsy.
TheclinicalpresentationofE.granulosusinfectiondependsuponthesiteofthecystsandtheirsize.Small
and/orcalcifiedcystsmayremainasymptomaticindefinitely.However,symptomsduetomasseffectwithin
organs,obstructionofbloodorlymphaticflow,orcomplicationssuchasruptureorsecondarybacterial
infectionscanresult.
Cyststypicallyincreaseindiameteratarateofonetofivecentimetersperyear.However,cystgrowthrates
andtimecoursesarehighlyvariable[1,2].Hydatidcystsmaybefoundinalmostanysiteofthebody,either
fromprimaryinoculationorviasecondaryspread.Theliverisaffectedinapproximatelytwothirdsofpatients,
thelungsinapproximately25percent,andotherorgansincludingthebrain,muscle,kidneys,bone,heart,and
pancreasinasmallproportionofpatients.Singleorganinvolvementoccursin85to90percentofpatientswith
E.granulosusinfection,andonlyonecystisobservedinmorethan70percentofcases(image1).
LiverinvolvementE.granulosusinfectionoftheliverfrequentlyproducesnosymptoms.Therightlobe
isaffectedin60to85percentofcases.Significantsymptomsareunusualbeforethecysthasreachedatleast
10cmindiameter.Ifthecystsbecomelarge,hepatomegalywithorwithoutassociatedrightupperquadrant
pain,nausea,andvomitingcanresult(picture1).
E.granulosuscystscanruptureintothebiliarytreeandproducebiliarycolic,obstructivejaundice,cholangitis,
orpancreatitis.(See"Endoscopicdiagnosisandmanagementofbiliaryparasitosis".)
Pressureormasseffectsonthebileducts,portalandhepaticveins,orontheinferiorvenacavacanresultin
cholestasis,portalhypertension,venousobstruction,ortheBuddChiarisyndrome.(See"EtiologyoftheBudd
Chiarisyndrome".)
Livercystscanalsoruptureintotheperitoneum,causingperitonitis,ortransdiaphragmaticallyintothepleural
spaceorbronchialtree,causingpulmonaryhydatidosisorabronchialfistula.Secondarybacterialinfectionof
thecystscanresultinliverabscesses.(See"Pyogenicliverabscess".)
LunginvolvementThemostcommonsymptomsofpulmonarycysticechinococcosis(CE)describedin
theliteratureincludecough(53to62percent),chestpain(49to91percent),dyspnea(10to70percent),and
http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elapse

1/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

hemoptysis(12to21percent).Lessfrequentsymptomsincludemalaise,nauseaandvomiting,andthoracic
deformations[3,4].Themajorityofchildrenandadolescentswithlunglesionsareasymptomaticdespitehaving
lesionsofimpressivesize,assumedlybecauseofaweakerimmuneresponseandtherelativelyhigher
elasticityofthelungparenchymarelativetoolderpatients[3,5].
Cystscanbreakordevelopsecondarybacterialinfection.Thepresenceofthesecomplicationschangesthe
clinicalpresentation,eitherbycausingnewsymptomsorbyincreasingtheseverityofexistingsymptoms.The
principalcomplicationiscystrupture,withspillingofcystmaterialcontainingfragmentsoflarvaltissueand
protoscolicesintothebronchialtreeorthepleuralcavity.Bronchialtreeinvolvementcanleadtocough,chest
pain,hemoptysis,oremesispleuralcavityinvolvementcancausepneumothorax,pleuraleffusion,or
empyema.Secondarybacterialinfectionofthecystcanmanifestasapulmonaryabscesswithpoorlydefined
margins[68].
Approximately60percentofpulmonaryhydatiddiseaseaffectstherightlung,and50to60percentofcases
involvethelowerlobes[9].Multiplecystsarecommon.Approximately20percentofpatientswithlungcysts
alsohavelivercysts[10].Theratiooflungtoliverinvolvementishigherinchildrenthaninadults[10].
OtherorgansInvolvementoforgansoutsideoftheliverorlungisunusualbutcanleadtosignificant
morbidityandmortality.
Infectionoftheheartcanresultinmechanicalrupturewithwidespreaddisseminationorpericardial
tamponade[11,12].
Centralnervoussysteminvolvementcanleadtoseizuresorsignsofraisedintracranialpressure
infectionofthespinalcordcanresultinspinalcordcompression[13].
Cystsinthekidneycancausehematuriaorflankpain[14].Immunecomplexmediateddisease,
glomerulonephritisleadingtothenephroticsyndrome,andsecondaryamyloidosishavealsobeen
described[15,16].
Bonecystsareusuallyasymptomaticuntilapathologicfracturedevelopsthespine,pelvis,andlong
bonesaremostfrequentlyaffected[17].
Ocularcystsalsooccur[18,19].
CystruptureFeverandacutehypersensitivityreactions,includinganaphylaxis,maybetheprincipal
manifestationsofcystrupture.Hypersensitivityreactionsarerelatedtothereleaseofantigenicmaterialand
secondaryimmunologicreactions.(See"Anaphylaxis:Rapidrecognitionandtreatment".)
OutcomeTheoutcomeofinfectionvarieswiththestageofthedisease.Onestudyreportedonthelong
termoutcomeof33patientswithasymptomaticliverhydatidcysts[1].Thenaturalhistoryofinfectionwas
variable.Approximately15percentofpatientshadundergonesurgery10to12yearsaftertheinitialdiagnosis.
Amongpatientswhodidnotundergosurgery,75percentremainedasymptomatic57percentdidnothavea
changeinthesizeofthecystbyimaging.
Calcificationusuallyrequires5to10yearstodevelopandoccursmostcommonlywithhepaticcystsbutrarely
withpulmonaryorbonecysts.Totalcalcificationofthecystwallsuggeststhatthecystmaybenonviable.
EchinococcusmultilocularisInfectionduetoE.multilocularisisusuallysymptomatic,althoughthe
clinicalmanifestationsarefrequentlynonspecific.Themostcommonpresentingcomplaintsincludemalaise,
weightloss,andrightupperquadrantdiscomfortduetohepatomegaly.Cholestaticjaundice,cholangitis,portal
hypertension,andtheBuddChiarisyndromecanalsooccur.Theclinicalpresentationmaymimicthatof
hepatocellularcarcinoma.
Extrahepaticprimarydiseaseisveryrare(1percentofcases).Multiorgandiseasewasdescribedin13percent
ofcasesinoneseriesinwhichmetacestodesinvolvedthelungs,spleen,orbraininadditiontotheliver[20].
Immunodeficiency,suchasHIVortransplantation,mayacceleratethemanifestationsofalveolar
echinococcosis[21].
Ifleftuntreated,morethan90percentofpatientswilldiewithin10yearsoftheonsetofclinicalsymptoms,and
http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elapse

2/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

virtually100percentwilldieby15years[22].Sincetreatmentwithalbendazolehasbeenintroduced,the
prognosishasimprovedconsiderably.Of117patientsfromFrancewhounderwentlongtermfollowup,the
actuarialsurvivalratewas88percent[23].Lifeexpectancyhasimproved,andpatientsundergoingradical
treatmenthaveabetteroutcomenowthan40yearsago.InSwitzerlandin1970,thelifeexpectancyforan
average54yearoldpatientwithechinococcosiswasestimatedtobereducedby18and21yearsformenand
women,respectivelyby2005,lifeexpectancywasreducedbyapproximately3.5and2.6yearsformenand
women,respectively[23].
DIAGNOSISBothcysticandalveolarEchinococcusmaybediagnosedwithacombinationofimagingand
serology[24].SerologicassaysforE.multilocularisinfectionaremoresensitiveandspecificthanforE.
granulosusinfection.ThefollowingdiscussionprimarilydealswiththemorecommonE.granulosusinfection,
exceptasindicated.Specificdiscussionrelatedtothediagnosisofalveolarechinococcosisfollowsbelow.
E.granulosusNonspecificleukopeniaorthrombocytopenia,mildeosinophilia,andnonspecificliverfunction
abnormalitiesmaybeobservedbutarenotdiagnostic.Eosinophiliaisobservedinfewerthan15percentof
casesandgenerallyoccursonlyifthereisleakageofantigenicmaterial.
ImagingHydatidcystsmaybevisualizedandevaluatedwithultrasonography,computedtomography
(CT),ormagneticresonanceimaging(MRI).Ultrasonographyisemployedmostwidelybecauseitiseasyto
performandrelativelyinexpensive.Portableultrasoundmachinesarefrequentlyusedforscreeningpatientsin
communitiesinwhichE.granulosusinfectionisendemic,sometimeswithconfirmatoryserologictestingto
maximizethediagnosticyield[25].However,CTorMRImaybeusefulforcircumstancesinwhichgreater
anatomicdetailisneededtoestablishthelocationandnumberofcysts,thepresenceorabsenceofdaughter
cysts,andpresenceofrupturedorcalcifiedcysts,whichareimportantforguidingmanagement(table1).
Plainradiographymaydemonstratecalcificationwithinacystbutcannotdetectuncalcifiedcystssoisnot
adequatefordefinitivediagnosticevaluation.
UltrasonographyThesensitivityofultrasonographyforevaluationofEchinococcusis90to95
percent[26,27].Themostcommonappearanceonultrasoundisananechoic,smooth,roundcyst,whichcan
bedifficulttodistinguishfromabenigncyst.Inthepresenceoflivercystmembranes,mixedechoescanbe
confusedwithanabscessorneoplasm.Inthepresenceofdaughtercysts,characteristicinternalseptationcan
beseen.
Shiftingthepatient'spositionduringultrasonographymaydemonstrate"hydatidsand,"whichconsists
predominantlyofhookletsandscolexesfromtheprotoscolices.Hydatiddiseaseisprobableinthesettingof
hydatidsand,innercystwallinfoldings,andseparationofthehydatidmembranefromthewallofthecyst
observedonultrasound[28].
Ultrasoundallowsclassificationofthecyst(s)asactive,transitional,orinactivebasedonbiologicactivity
suchcategorizationsmayinfluencethechoiceoftreatment(image2).Characteristicssuggestiveofaninactive
lesionincludeacollapsing,flattenedellipticalcyst(correspondstolowpressurewithinthecyst),detachmentof
thegerminallayerfromthecystwall("waterlilysign"),coarseechoeswithinthecyst,andcystwall
calcification[29,30].Cystswithacalcifiedrimmayhavean"eggshell"appearance.
Severalotherclassificationsystemsarebaseduponultrasoundappearance(image2):
TheWorldHealthOrganization(WHO)classificationcharacterizescystsbytypeandsize(table1)
[31,32].
TheGharbiclassificationdividescystsintofivetypes[33].TypeIcystsconsistofpurefluidtypeIIhave
afluidcollectionwithasplitwalltypeIIIcystscontaindaughtercysts(withorwithoutdegeneratedsolid
material)typeIVhaveaheterogeneousechopatternandtypeVhaveacalcifiedwall[33].
WHOcategoriesCE1andCE2areactivecysts.TypeCE1isunilocularandtypeCE2ismultilocularwith
daughtercysts(figure1).ClassCE3consistsofcyststhatarethoughttobedegenerating(transitionalgroup).
TherearetwotypesofCE3:CE3a,featuringthe"waterlily"signforfloatingmembranes,andCE3b,whichis
predominantlysolidwithdaughtercysts.Establishingwhetherdaughtercystsarepresentisimportantfor
guidingtreatment.Inaddition,nuclearmagneticresonancehasdemonstratedthatCE3aandCE3bhave
http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elapse

3/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

differentmetaboliccharacteristics[34].ClassesCE4andCE5areconsideredinactive.Byultrasonography,
theyareechogenicwithincreasingdegreesofcalcificationandarenearlyalwaysnonviable.
Itisimportanttoestablishwhetherdaughtercysts(cyststhathaveinvolutedfromthewallandresidewithin
thelargercyst)arepresentandtodistinguishthemfrombroodcapsules,whichareattachedtothewallofthe
largercyst.Thisdistinctionisimportantforguidingtreatment.
Lungcystsmaybesingleormultiple,usuallydonotcalcify,rarelyleadtodaughtercystformation,andmay
containairifthecysthasruptured.
ComputedtomographyManyreportssuggestthatcomputedtomography(CT)hashigheroverall
sensitivitythanultrasonography(95to100percent)[26,27,35].CTisthebestmodefordeterminingthe
number,size,andanatomiclocationofthecystsandisbetterthanultrasoundfordetectionofextrahepatic
cysts.CTmayalsobeusedformonitoringlesionsduringtherapyandtodetectrecurrences(image1)[36].
CTmaybesuperiortoultrasonographyinassessingforcomplicationssuchasinfectionandintrabiliaryrupture
[37].Inonestudy,ultrasoundperformedbetterthanCTintheinvestigationofthecystwall,hydatidsand,
daughtercysts,andsplittingofthecystwall,whileCTwassuperiorfordetectinggasandminutecalcifications
withinthecysts,inattenuationmeasurement,andinanatomicmapping[30,38].
MagneticresonanceimagingMagneticresonanceimaging(MRI)hasnomajoradvantageoverCT
forevaluationofabdominalorpulmonaryhydatidcysts,exceptindefiningchangesintheintraand
extrahepaticvenoussystem[39].MRImaydelineatethecystcapsulebetterthanCTandmaybebetterat
diagnosingcomplications,particularlyforcystswithinfectionorbiliarycommunication.However,MRIis
usuallynotrequiredand,inmostinstances,isnotcosteffective[4042].
BothCTandMRIareusefulindiagnosingechinococcalinfectioninothersitessuchasinthebrain[43].
OtherOtherimagingtechniquessuchascholangiographymaybeindicatedtodiagnosebiliary
involvement,particularlyinpatientswithcholestaticjaundice.Endoscopicretrogradecholangiopancreatography
(ERCP)ormagneticresonancecholangiopancreatography(MRCP)isfrequentlyperformedinpatientswithliver
cystspriortointerventiontoascertainpotentialinvolvementofthebiliarysystemandtoguidethetreatment
approach.(See"Endoscopicdiagnosisandmanagementofbiliaryparasitosis".)
SerologicandantigenassaysSerologyisusefulforprimarydiagnosisandforfollowupaftertreatment
[20,44,45].AntibodydetectionismoresensitivethanantigendetectionfordiagnosisofE.granulosus[20].
LaboratoryserologictoolsDiagnosticserologictechniquesinclude:

Complementfixation
Indirecthemagglutination(IHA)
Indirectimmunofluorescence
Latexagglutination
Doublediffusionimmunoelectrophoresis
Countercurrentimmunoelectrophoresis(CIEP)
Radioimmunoassay(RIA)
Enzymelinkedimmunosorbentassay(ELISA)
Enzymelinkedimmunoelectrodiffusionassay(ELIEDA)
Timeresolvedfluoroimmunoassay(TRFLA)
Immunoblot

Thesensitivityandspecificityofanumberoftheserologictestshavebeencompared(table2).ELISAappears
tobethemostsensitiveandspecificoftheavailableassays[4651]:
Onestudyof79patientswithsurgicallyconfirmedpulmonaryhydatidosisdemonstratedthatIgGELISA
wasthemostsensitive(84percent),followedbyIgMELISA(62percent),passivehemagglutination(61
percent),latexagglutination(58percent),immunoelectrophoresis(51percent),andspecificIgEELISA(44
percent).Thespecificityofalltestswas98to100percent.SpecificIgGELISAhadthehighestnegative
http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elapse

4/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

predictivevalue(93percent)[46].
Onestudycomparedeightserologictestsamong131patientswithE.granulosusinfection[49].IgG
ELISAwasthemostsensitive(94percent)andspecific(99percent)forthemajorityofcystlocations.
Onereportcomparedsixdifferentserologictestsforthediagnosisofcystichydatiddiseaseamong243
patientswithsurgicallyconfirmedinfection[50].ThetwoELISAtestsgaveidenticalresults,witha
sensitivityof89percentforlivercystsand78percentforlungcysts.Inthe39patientswithfalse
negativeresults,theuseofimmunoblottingonlyincreasedtheyieldby8percentELIEDAdidnotidentify
anyadditionalcases.
Themethodsmostfrequentlyemployedforinitialscreeningtests(usingcrudeantigenssuchashydatidfluidor
protoscolexextracts)areELISAandIHA.Confirmatorytestsusingspecificantigenscanthenbeperformed,
suchasimmunoelectrophoresisandimmunoblotting[48].Additionaltestsusingrecombinantorpurified
speciesspecificantigensmayalsobeusefuldiagnosis[52].
Simple,heatstable,inexpensivetests,suchashydatidantigendotimmunoassays,areoftenusedforfield
testingandpopulationscreening[53].ThedotELISAhasareportedsensitivityof88to96percentanda
specificityof90to98percent[5456].
TwomajorE.granulosusantigensutilizedinserologictestingincludeantigen5andantigenB:
Antigen5isamajorparasiteantigenfoundontheinneraspectofthegerminallayer,broodcapsule,and
protoscolices.Onlyafewstudieshaveassessedthevalueoftestsbasedonrecombinantantigen5,
whichhasrelativelylowspecificity,althoughitisusedquiteextensivelyfordiagnosisinclinicalpractice
[48].
AntigenBisahighlyimmunogenicpolymericlipoprotein.StudieshaveshowedthatantigenBshowsa
highdegreeofgeneticvariability[57].Itoffersgreaterspecificitythandetectionofantigen5however,
neitherantigenisspecificforE.granulosuspersedespiteaveryhighspecificityforechinococcal
infection[58,59].
ThesensitivityoftheseantigensinELISAassaysis60to90percentandthespecificityisusually
approximately90percent[60].Thesensitivityinimmunoblotandgeldiffusionassaysisapproximately90
percentwithaspecificityof97to100percent[59,61].Onestudydemonstratedthattheimmunoblotwiththe
antigenBrichfractionwaspositivein92percentofpatientswithE.granulosusbutwasalsopositivein79
percentofpatientswithE.multilocularis[62].Nocrossreactivitywasobservedwithserafrompatientswith
otherparasiticdiseases,malignancies,orhealthycontrols.
Avarietyofissuesinfluencetheratesoffalsepositiveandfalsenegativeserologicresults.First,thereisa
lackofstandardizationamongdifferentlaboratoriesforexample,onestudyshowedthatELISAusingantigen
Bhadasensitivityof63percent,whereasimmunoblottingusingthesameantigenhadasensitivityof80
percent[63].Second,methodsofantigenisolationandpurificationcaninfluencetheresults.Third,serological
assayswithhighsensitivityandspecificityfordiagnosisofcysticechinococcosisinclinicalsettingscanbe
lessusefulinepidemiologicalstudiestheseassaysmaydetectonlyhalfoflivercystsinfieldsurveysandas
fewas20percentoflungcysts[64,65].
Theutilityofserologycanbeimprovedbyusingacombinationoftestsorsequentialtesting[66].Tests
employinganumberofrecombinantantigensarebeingevaluatedtoimprovethesensitivityandspecificityof
thecommerciallyavailableserologictests.Ahighlysensitiveassay,usuallyanELISAorindirect
hemagglutinationtest,iscommonlyusedasaninitialscreen,followedbyahighlyspecificimmunoblotorgel
diffusionassayforconfirmation.Testingforspecificantibodies,suchasspecificIgG1orIgG4ratherthantotal
IgG,mayimprovespecificity[63,6769].
ClinicalfactorsAnegativeserologictestgenerallydoesnotruleoutechinococcosis.Thereisno
consistentcorrelationbetweenserologicresultsandthenumberorsizeofcysts[46].Ingeneral,livercysts
elicitanantibodyresponsemorefrequentlythanlungcysts.Overall,approximately85to95percentofliver
cystsand65percentoflungcystsareassociatedwithpositiveserology,althoughthisvarieswiththespecific
serologictestusedandcystactivity[47].Brain,eye,andspleniccystsoftendonotproducedetectable
http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elapse

5/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

antibodies,whereasbonecystsfrequentlyareassociatedwithpositiveserology.Serologyislesslikelytobe
positivewithcystsatanysiteifthecystsareintact,calcified,ornonviable.
Thelikelihoodoffalsenegativeresultsisvariabledependingonthelesionsiteofthelesionandtheintegrity
andviabilityofthecyst.Antigenantibodycomplexesthat"mop"upallantibodiesmayleadtofalsenegative
reactions.Childrenandpregnantwomenmorefrequentlyhavenegativeserologythanotherpatientpopulations
[9].Falsepositivereactionsaremorelikelyinthepresenceofotherhelminthinfections(suchasTaenia
saginata,Taeniasolium,andparticularlyneurocysticercosis),cancer,andimmunedisorders.
AntigenassaysAvarietyofpurifiedorrecombinantdiagnosticantigenshavebeenevaluated.
Demonstrationofantigensincysticfluidorserumcanalsobeusedfordiagnosisofprimaryinfectionorrelapse
[66,70,71].However,upto50percentofpatientswithechinococcalcystsdonothavecirculatingantigens.
LatexagglutinationoradotELISAtodetectechinococcalantigensfromcystfluidhaveexcellentsensitivity
andspecificity[7274].Antigenassaysandtestsforcirculatingimmunecomplexesarenotwidelyavailablebut
maybecomeusefulsecondarytestsinthefuture[75].
E.multilocularisNonspecificleukopeniaorthrombocytopenia,mildeosinophilia,andnonspecificliver
functionabnormalitiesmaybedetectedbutarenotdiagnostic.Hypergammaglobulinemiaandelevatedserum
IgElevelsarepresentinmorethan50percentofcases.
ImagingThediagnosisofE.multilocularisisgenerallymadebyimagingtechniquesinconjunctionwith
serology.OnultrasoundorCT,thelesionsusuallyhaveanirregularcontourwithnowelldefinedwall,central
necrosis,andirregularintralesionalandwallcalcifications.Theymaybedifficulttodistinguishfromatumor,
butthepatient'soverallconditionisusuallybetterthanwouldbeexpectedforamalignancy.
Obstructionoftheinferiorvenacavaoroftheportalvenoussystemmaybeevident,whichmaybemoreeasily
appreciatedonMRI.Lung,brain,andbonelesionsmayalsobedetected.
SerologySerologictestsaremorereliablefordiagnosisofE.multilocularisinfectionthanforE.
granulosusinfectionsensitivityandspecificityratesare95to100percent[76].AspecificE.multilocularis
antigensuchastheaffinitypurifiedEm2antigenfromAEmetacestodesisoftenusedtheEm2ELISAcan
discriminatebetweenE.granulosusandE.multilocularisin95percentofcases.Serologyusuallyremains
positiveindefinitelyfollowingcompletesurgicalresection,serologymaynormalizewithinafewyears[77].The
Em2ELISAfrequentlybecomesnegativewithinfouryearsofsurgeryandbecomespositiveagaininthe
settingofarecurrence[76,78,79].AnEm2plusELISAassayusesadditionalspeciesspecificantigensithas
sensitivityandspecificityof97and99percent,respectively,andisalsousefulformonitoringrecurrence
followingsurgicalresection[8082].Thesetestsmaynotbereadilyavailableandmaybefoundonlyin
specializedcenters.
ELISAandimmunoblotstudiesusingEm18,an18kDprotoscolexantigen,aresensitiveandhighlyspecies
specific[62,8387].Theantigenisalsousefulfordifferentiatingbetweenactiveandinactiveinfectionandis
usefulforfollowupofpatientsontreatment[82,83,88,89].
Clinicalrecurrenceisfrequentlyassociatedwithrisingserologictiters.IgG1andIgG4antibodiesarethemost
sensitiveisotypesformonitoringsuccessoftherapy[83].
CystaspirationorbiopsyIntheabsenceofapositiveserologictest,percutaneousaspirationorbiopsy
mayberequiredtoconfirmthediagnosisbydemonstratingthepresenceofprotoscolices,hooklets,orhydatid
membranes.Percutaneousaspirationoflivercystcontentsisassociatedwithverylowratesofcomplications,
butthismethodofdiagnosisisgenerallyreservedforsituationswhenotherdiagnosticmethodsare
inconclusivebecauseofthepotentialforanaphylaxisandsecondaryspreadoftheinfection[9093].
Activecystshaveclear,wateryfluidcontainingscolicesandelevatedpressureinactivecystshavecloudy
fluidwithoutdetectablescolicesanddonothaveelevatedpressure[29].Inthesettingoflungcysts,
protoscolicesordegeneratedhookletsmaybedemonstrableinsputumorbronchialwashings.Avarietyof
stainingmethodstodetectparasiticmaterialcanbeused.Stainsforvisualizationofhydatidelementsinclude
RyantrichromebluestainandmodifiedBaxbystain.ZiehlNeelsenstainisalsousefulundergreenexcitation
light(546nm),thehydatidelementshaveafluorescentbrightredappearance[94].
http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elapse

6/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

Ifaspirationisrequired,itshouldbeperformedunderultrasoundorCTguidancecomplicationscanbe
minimizedbyconcurrentadministrationofalbendazoleandpraziquantel[95].(See"Treatmentof
echinococcosis".)
PolymerasechainreactionPolymerasechainreaction(PCR)techniquesarelimitedtoresearchsettings
butmayplayadiagnosticroleinthefuture[96].DNAprobesusingSouthernhybridizationtestsarealsobeing
developed[80].
DIFFERENTIALDIAGNOSISIngeneral,anymassoccupyinglesionmayclinicallyresemblean
echinococcalcyst.Thedifferentialdiagnosisofcysticechinococcosisincludes[97]:
SimplebenigncystPatientswithsymptomaticlivercystmaypresentwithabdominaldiscomfort,pain,
ornausea.LivercystsaredistinguishedfromEchinococcusbyultrasonography.(See"Diagnosisand
managementofcysticlesionsoftheliver".)
HemangiomaHemangiomaisusuallyanincidentalfindingidentifiedinthesettingofradiographic
imagingorlaparotomythemostcommonsymptomsareabdominalpainandrightupperquadrant
fullness.Thediagnosisofhemangiomaisgenerallyestablishedradiographically.(See"Hepatic
hemangioma".)
HepatocellularcarcinomaPatientswithhepatocellularcarcinomaareusuallyasymptomaticintheearly
stagestheyaredistinguishedfrompatientswithcysticEchinococcusbasedonclinicalhistoryand
imaging.(See"Clinicalfeaturesanddiagnosisofprimaryhepatocellularcarcinoma".)
AbscessAliverorlungabscessmayresembleanEchinococcuscystclinicallyandradiographically.
Liverabscessisevaluatedbyaspirationlungabscessmaybeevaluatedviabronchoscopyoraspiration.
Inthesettingofsuspicionforechinococcosis,percutaneousaspirationorbiopsyshouldbereservedfor
situationswhenotherdiagnosticmethodsareinconclusivebecauseofthepotentialforanaphylaxisand
secondaryspreadoftheinfection.(See"Pyogenicliverabscess"and"Lungabscess".)
TuberculosisAcavitarytuberculosislesionmayresembleanEchinococcuscystonradiographic
imaging.Thediagnosisoftuberculosisisestablishedbasedonthepresenceofacidfastbacillionsmear
andculture.(See"Clinicalmanifestationsandevaluationofpulmonarytuberculosis".)
ThedifferentialdiagnosisofalveolarEchinococcusincludes:
CirrhosisPatientswithcirrhosismayhaveanorexia,weightloss,weakness,andfatiguepatientswith
alveolarEchinococcusmayhavemalaise,weightloss,andrightupperquadrantdiscomfort.Thetwoare
distinguishedbasedonradiographicimagingandlaboratorydata.(See"Cirrhosisinadults:Etiologies,
clinicalmanifestations,anddiagnosis".)
Malignancy(hepatocellularcarcinomaorlivermetastases)Patientswithlivertumorsaregenerally
distinguishedfromthosewithalveolarEchinococcusbasedonradiographicimaging.(See"Solidliver
lesions:Differentialdiagnosisandevaluation".)
SUMMARY
E.granulosusinfectionisinitiallyasymptomaticandmayremainsoformanyyears.Subsequentclinical
featuresandcomplicationsdependuponthesiteandsizeofthecyst(s).Theliverandlungsareaffected
inapproximately67and25percentofcases,respectively.Mostpatientshavesingleorganinvolvement,
andasinglecystispresentinmorethan70percentofcases.Thelongtermoutcomeisvariableand
manypatientsremainasymptomatic.(See'Echinococcusgranulosus'above.)
E.multilocularisinfectionismorelikelytobesymptomaticthanE.granulosusinfection.Themost
commonclinicalmanifestationsincluderightupperquadrantdiscomfort,malaise,andweightloss,and
thepicturemaymimicthatassociatedwithhepatocellularcarcinoma.Intheabsenceoftreatment,more
than90percentofpatientswithalveolarechinococcosisdiewithin10yearsoftheonsetofclinical
symptoms.(See'Echinococcusmultilocularis'above.)
Thediagnosisofechinococcosisistypicallyestablishedbyultrasoundimaging(table1andimage2)in
http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elapse

7/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

combinationwithserologictesting(usuallyenzymelinkedimmunosorbentassay[ELISA]).Hydatid
diseaseisprobableinthesettingofultrasounddemonstratinginfoldingsoftheinnercystwall,separation
ofthehydatidmembranefromthewallofthecyst,orhydatidsand.E.multilocularislesionsmayhavean
irregularcontourandmaybedifficulttodifferentiatefromtumor.(See'Ultrasonography'above.)
Diagnosticjudgmentmusttakeintoconsiderationthelimitationsofserologictesting.Thelikelihoodofa
positiveserologydependsoncystlocationandviability.Patientswithlivercystsaremorelikelytobe
seropositivethanpatientswithlungcysts.Serologicassaysarelesslikelytobepositiveinthesettingof
calcifiedornonviablecysts.Inaddition,thesensitivityandspecificityofserologyisgreaterforE.
multilocularisthanforE.granulosus.(See'Serologicandantigenassays'above.)
Percutaneousaspirationorbiopsyshouldbereservedforsituationswhenotherdiagnosticmethodsare
inconclusivebecauseofthepotentialforanaphylaxisandsecondaryspreadoftheinfection.Ifaspiration
isrequired,itshouldbeperformedunderultrasoundorCTguidance.Complicationscanbeminimizedby
concurrentadministrationofalbendazoleandpraziquantel.(See'Cystaspirationorbiopsy'above.)
ACKNOWLEDGMENTTheeditorialstaffatUpToDate,Inc.wouldliketoacknowledgeDr.KarinLederand
Dr.PeterWeller,whocontributedtoanearlierversionofthistopicreview.
UseofUpToDateissubjecttotheSubscriptionandLicenseAgreement.
REFERENCES
1. FriderB,LarrieuE,OdriozolaM.Longtermoutcomeofasymptomaticliverhydatidosis.JHepatol1999
30:228.
2. MoroPL,GilmanRH,VerasteguiM,etal.HumanhydatidosisinthecentralAndesofPeru:evolutionof
thediseaseover3years.ClinInfectDis199929:807.
3. SantivanezS,GarciaHH.Pulmonarycysticechinococcosis.CurrOpinPulmMed201016:257.
4. ArincS,KosifA,ErtugrulM,etal.Evaluationofpulmonaryhydatidcystcases.IntJSurg20097:192.
5. ArroudM,AfifiMA,ElGhaziK,etal.Lunghydaticcystsinchildren:comparisonstudybetweengiant
andnongiantcysts.PediatrSurgInt200925:37.
6. DopchizMC,ElissondoMC,AndresiukMV,etal.PediatrichydatidosisinthesoutheastoftheBuenos
Airesprovince,Argentina.RevArgentMicrobiol200941:105.
7. TurgutAT,AltinokT,TopuS,KoarU.Localcomplicationsofhydatiddiseaseinvolvingthoracic
cavity:imagingfindings.EurJRadiol200970:49.
8. DziriC,HaouetK,FingerhutA,ZaoucheA.Managementofcysticechinococcosiscomplicationsand
dissemination:whereistheevidence?WorldJSurg200933:1266.
9. BhatiaG.Echinococcus.SeminRespirInfect199712:171.
10. BadenLR,ElliottDD.CaserecordsoftheMassachusettsGeneralHospital.WeeklyClinicopathological
exercises.Case42003.A42yearoldwomanwithcough,fever,andabnormalitiesonthoracoabdominal
computedtomography.NEnglJMed2003348:447.
11. BenHamdaK,MaatoukF,BenFarhatM,etal.Eighteenyearexperiencewithechinococcosusofthe
heart:clinicalandechocardiographicfeaturesin14patients.IntJCardiol200391:145.
12. DazMenndezM,PrezMolinaJA,NormanFF,etal.Managementandoutcomeofcardiacand
endovascularcysticechinococcosis.PLoSNeglTropDis20126:e1437.
13. NourbakhshA,VannemreddyP,MinagarA,etal.Hydatiddiseaseofthecentralnervoussystem:a
reviewofliteraturewithanemphasisonLatinAmericancountries.NeurolRes201032:245.
14. GC,SafakM,BaltaciS,TrklmezK.Isolatedrenalhydatidosis:experiencewith20cases.JUrol
2003169:186.
15. AliKhanZ,RauschRL.Demonstrationofamyloidandimmunecomplexdepositsinrenalandhepatic
parenchymaofAlaskanalveolarhydatiddiseasepatients.AnnTropMedParasitol198781:381.
16. GelmanR,BrookG,GreenJ,etal.Minimalchangeglomerulonephritisassociatedwithhydatiddisease.
ClinNephrol200053:152.
17. ZlitniM,EzzaouiaK,LebibH,etal.Hydatidcystofbone:diagnosisandtreatment.WorldJSurg2001
25:75.
http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elapse

8/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

18. ChaabouniM,BenZinaZ,BenAyezH,etal.[Hydatidorbitalcyst:auniqueintraorbitallocality.Acase
report].JFrOphtalmol199922:329.
19. SinavS,DemirciA,SinavB,etal.Aprimaryintraocularhydatidcyst.ActaOphthalmol(Copenh)1991
69:802.
20. McManusDP,ZhangW,LiJ,BartleyPB.Echinococcosis.Lancet2003362:1295.
21. KernP,BardonnetK,RennerE,etal.Europeanechinococcosisregistry:humanalveolar
echinococcosis,Europe,19822000.EmergInfectDis20039:343.
22. AmmannRW,EckertJ.Cestodes.Echinococcus.GastroenterolClinNorthAm199625:655.
23. TorgersonPR,SchweigerA,DeplazesP,etal.Alveolarechinococcosis:fromadeadlydiseasetoa
wellcontrolledinfection.RelativesurvivalandeconomicanalysisinSwitzerlandoverthelast35years.J
Hepatol200849:72.
24. MorarR,FeldmanC.Pulmonaryechinococcosis.EurRespirJ200321:1069.
25. BarbieriM,SeveriMA,PrezMI,etal.Useofspecificantibodyandcirculatingantigenserumlevelsin
thehydatidimmunodiagnosisofasymptomaticpopulation.IntJParasitol199424:937.
26. DharP,ChaudharyA,DesaiR,etal.Currenttrendsinthediagnosisandmanagementofcystichydatid
diseaseoftheliver.JCommunDis199628:221.
27. SafioleasM,MisiakosE,MantiC,etal.Diagnosticevaluationandsurgicalmanagementofhydatid
diseaseoftheliver.WorldJSurg199418:859.
28. PantCS,GuptaRK.Diagnosticvalueofultrasonographyinhydatiddiseaseinabdomenandchest.Acta
Radiol198728:743.
29. SalamaH,FaridAbdelWahabM,StricklandGT.Diagnosisandtreatmentofhepatichydatidcystswith
theaidofechoguidedpercutaneouscystpuncture.ClinInfectDis199521:1372.
30. SuwanZ.Sonographicfindingsinhydatiddiseaseoftheliver:comparisonwithotherimagingmethods.
AnnTropMedParasitol199589:261.
31. WHOInformalWorkingGroup.Internationalclassificationofultrasoundimagesincysticechinococcosis
forapplicationinclinicalandfieldepidemiologicalsettings.ActaTrop200385:253.
32. http://www.medicalweb.it/aumi/echinonet/(AccessedonDecember04,2012).
33. GharbiHA,HassineW,BraunerMW,DupuchK.Ultrasoundexaminationofthehydaticliver.Radiology
1981139:459.
34. HoschW,StojkovicM,JnischT,etal.MRimagingfordiagnosingcystobiliaryfistulasincystic
echinococcosis.EurJRadiol200866:262.
35. XynosE,PechlivanidesG,TzortzinisA,etal.Hydatiddiseaseoftheliver.Diagnosisandsurgical
treatment.HPBSurg19914:59.
36. elTahirMI,OmojolaMF,MalataniT,etal.Hydatiddiseaseoftheliver:evaluationofultrasoundand
computedtomography.BrJRadiol199265:390.
37. KervanciogluR,BayramM,ElbeyliL.CTfindingsinpulmonaryhydatiddisease.ActaRadiol1999
40:510.
38. alKarawiMA,elShiekhMohamedAR,YasawyMI.Advancesindiagnosisandmanagementofhydatid
disease.Hepatogastroenterology199037:327.
39. MaraniSA,CanossiGC,NicoliFA,etal.Hydatiddisease:MRimagingstudy.Radiology1990175:701.
40. vonSinnerWN,RifaiA,teStrakeL,SieckJ.Magneticresonanceimagingofthoracichydatiddisease.
Correlationwithclinicalfindings,radiography,ultrasonography,CTandpathology.ActaRadiol1990
31:59.
41. MorrisDL,BuckleyJ,GregsonR,WorthingtonBS.Magneticresonanceimaginginhydatiddisease.Clin
Radiol198738:141.
42. TaourelP,MartyAneB,CharassetS,etal.Hydatidcystoftheliver:comparisonofCTandMRI.J
ComputAssistTomogr199317:80.
43. TznM,AltinrsN,ArdaIS,HekimoluB.CerebralhydatiddiseaseCTandMRfindings.ClinImaging
200226:353.
44. RiganR,ProfumoE,IoppoloS,etal.Immunologicalmarkersindicatingtheeffectivenessof
pharmacologicaltreatmentinhumanhydatiddisease.ClinExpImmunol1995102:281.
45. RiganR,IoppoloS,OrtonaE,etal.Longtermserologicalevaluationofpatientswithcystic
echinococcosistreatedwithbenzimidazolecarbamates.ClinExpImmunol2002129:485.
http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elapse

9/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

46. ZarzosaMP,OrduaDomingoA,GutirrezP,etal.Evaluationofsixserologicaltestsindiagnosisand
postoperativecontrolofpulmonaryhydatiddiseasepatients.DiagnMicrobiolInfectDis199935:255.
47. BiavaMF,DaoA,FortierB.Laboratorydiagnosisofcystichydaticdisease.WorldJSurg200125:10.
48. OrtonaE,RiganR,ButtariB,etal.Anupdateonimmunodiagnosisofcysticechinococcosis.ActaTrop
200385:165.
49. ForceL,TorresJM,CarrilloA,BuscJ.Evaluationofeightserologicaltestsinthediagnosisofhuman
echinococcosisandfollowup.ClinInfectDis199215:473.
50. BabbaH,MessediA,MasmoudiS,etal.Diagnosisofhumanhydatidosis:comparisonbetweenimagery
andsixserologictechniques.AmJTropMedHyg199450:64.
51. SbihiY,RmiquiA,RodriguezCabezasMN,etal.Comparativesensitivityofsixserologicaltestsand
diagnosticvalueofELISAusingpurifiedantigeninhydatidosis.JClinLabAnal200115:14.
52. SilesLucasMM,GottsteinBB.Moleculartoolsforthediagnosisofcysticandalveolarechinococcosis.
TropMedIntHealth20016:463.
53. ParijaSC.Areviewofsomesimpleimmunoassaysintheserodiagnosisofcystichydatiddisease.Acta
Trop199870:17.
54. RoganMT,CraigPS,ZeyhleE,etal.EvaluationofarapiddotELISAasafieldtestforthediagnosisof
cystichydatiddisease.TransRSocTropMedHyg199185:773.
55. RomiaSA,YoussefME,HandoussaAE,etal.DotELISAasadiagnostictestinhydatiddisease.J
EgyptSocParasitol199222:603.
56. PappasMG,SchantzPM,CannonLTSr,WahlquistSP.DotELISAfortherapidserodiagnosisof
humanhydatiddisease.DiagnImmunol19864:271.
57. MamutiW,SakoY,NakaoM,etal.RecentadvancesincharacterizationofEchinococcusantigenB.
ParasitolInt200655Suppl:S57.
58. MaddisonSE,SlemendaSB,SchantzPM,etal.AspecificdiagnosticantigenofEchinococcus
granulosuswithanapparentmolecularweightof8kDA.AmJTropMedHyg198940:377.
59. PorettiD,FelleisenE,GrimmF,etal.Differentialimmunodiagnosisbetweencystichydatiddiseaseand
othercrossreactivepathologies.AmJTropMedHyg199960:193.
60. KaddahMH,MaherKM,HassaneinHI,etal.Evaluationofdifferentimmunodiagnostictechniquesfor
diagnosisofhydatidosisinEgypt.JEgyptSocParasitol199222:653.
61. SiracusanoA,IoppoloS,NotargiacomoS,etal.DetectionofantibodiesagainstEchinococcus
granulosusmajorantigensandtheirsubunitsbyimmunoblotting.TransRSocTropMedHyg1991
85:239.
62. ItoA,MaL,SchantzPM,etal.Differentialserodiagnosisforcysticandalveolarechinococcosisusing
fractionsofEchinococcusgranulosuscystfluid(antigenB)andE.multilocularisprotoscolex(EM18).Am
JTropMedHyg199960:188.
63. IoppoloS,NotargiacomoS,ProfumoE,etal.ImmunologicalresponsestoantigenBfromEchinococcus
granulosuscystfluidinhydatidpatients.ParasiteImmunol199618:571.
64. MoroPL,BonifacioN,GilmanRH,etal.FielddiagnosisofEchinococcusgranulosusinfectionamong
intermediateanddefinitivehostsinanendemicfocusofhumancysticechinococcosis.TransRSoc
TropMedHyg199993:611.
65. GavidiaCM,GonzalezAE,ZhangW,etal.Diagnosisofcysticechinococcosis,centralPeruvian
Highlands.EmergInfectDis200814:260.
66. ParijaSC.Recenttrendsintheserodiagnosisofhydatiddisease.SoutheastAsianJTropMedPublic
Health199122Suppl:371.
67. RamzyRM,HelmyH,ElZayyatEA,etal.Anenzymelinkedimmunosorbentassayfordetectionof
IgG1antibodiesspecifictohumancysticechinococcosisinEgypt.TropMedIntHealth19994:616.
68. VirginioVG,HernndezA,RottMB,etal.AsetofrecombinantantigensfromEchinococcusgranulosus
withpotentialforuseintheimmunodiagnosisofhumancystichydatiddisease.ClinExpImmunol2003
132:309.
69. LawnSD,BlighJ,CraigPS,ChiodiniPL.Humancysticechinococcosis:evaluationofposttreatment
serologicfollowupbyIgGsubclassantibodydetection.AmJTropMedHyg200470:329.
70. CraigPS,BaileyW,NelsonGS.Aspecifictestfortheidentificationofcystfluidsamplesfrom
suspectedhumanhydatidinfections.TransRSocTropMedHyg198680:256.
71. RavinderPT,ParijaSC.Countercurrentimmunoelectrophoresistestfordetectionofhydatidantigenin
thefluidfromhydatidcysts:apreliminaryreport.ActaTrop199766:169.
http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elaps

10/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

72. DeviChandrakesanS,ParijaSC.Latexagglutinationtest(LAT)forantigendetectioninthecysticfluid
forthediagnosisofcysticechinococcosis.DiagnMicrobiolInfectDis200345:123.
73. WangY,BradshawH,RoganMT,CraigPS.RapiddotELISAforthedetectionofspecificantigensin
thecystfluidfromhumancasesofcysticechinococcosis.AnnTropMedParasitol200296:691.
74. DeviCS,ParijaSC.Anewserumhydatidantigendetectiontestfordiagnosisofcysticechinococcosis.
AmJTropMedHyg200369:525.
75. GottsteinB.Animmunoassayforthedetectionofcirculatingantigensinhumanechinococcosis.AmJ
TropMedHyg198433:1185.
76. LanierAP,TrujilloDE,SchantzPM,etal.Comparisonofserologictestsforthediagnosisandfollowup
ofalveolarhydatiddisease.AmJTropMedHyg198737:609.
77. SchantzPM,WilsonJF,WahlquistSP,etal.Serologictestsfordiagnosisandposttreatmentevaluation
ofpatientswithalveolarhydatiddisease(Echinococcusmultilocularis).AmJTropMedHyg1983
32:1381.
78. GottsteinB,TschudiK,EckertJ,AmmannR.Em2ELISAforthefollowupofalveolarechinococcosis
aftercompletesurgicalresectionofliverlesions.TransRSocTropMedHyg198983:389.
79. DeplazesP,GottsteinB.AmonoclonalantibodyagainstEchinococcusmultilocularisEm2antigen.
Parasitology1991103Pt1:41.
80. GottsteinB.Molecularandimmunologicaldiagnosisofechinococcosis.ClinMicrobiolRev19925:248.
81. GottsteinB,JacquierP,BressonHadniS,EckertJ.Improvedprimaryimmunodiagnosisofalveolar
echinococcosisinhumansbyanenzymelinkedimmunosorbentassayusingtheEm2plusantigen.JClin
Microbiol199331:373.
82. MaL,ItoA,LiuYH,etal.Alveolarechinococcosis:Em2plusELISAandEm18westernblotsforfollow
upaftertreatmentwithalbendazole.TransRSocTropMedHyg199791:476.
83. ItoA,SchantzPM,WilsonJF.Em18,anewserodiagnosticmarkerfordifferentiationofactiveand
inactivecasesofalveolarhydatiddisease.AmJTropMedHyg199552:41.
84. AkiraI.Serodiagnosisofalveolarechinococcosis:detectionofantibodyagainstEM18inpatientsand
rodents.SoutheastAsianJTropMedPublicHealth199728Suppl1:117.
85. ItoA,NakaoM,KutsumiH,etal.Serodiagnosisofalveolarhydatiddiseasebywesternblotting.TransR
SocTropMedHyg199387:170.
86. ItoA,XiaoN,LianceM,etal.Evaluationofanenzymelinkedimmunosorbentassay(ELISA)with
affinitypurifiedEm18andanELISAwithrecombinantEm18fordifferentialdiagnosisofalveolar
echinococcosis:resultsofablindtest.JClinMicrobiol200240:4161.
87. JiangL,WenH,ItoA.Immunodiagnosticdifferentiationofalveolarandcysticechinococcosisusing
ELISAtestwith18kDaantigenextractedfromEchinococcusprotoscoleces.TransRSocTropMed
Hyg200195:285.
88. SakoY,NakaoM,NakayaK,etal.Alveolarechinococcosis:characterizationofdiagnosticantigen
Em18andserologicalevaluationofrecombinantEm18.JClinMicrobiol200240:2760.
89. FujimotoY,ItoA,IshikawaY,etal.UsefulnessofrecombinantEm18ELISAtoevaluateefficacyof
treatmentinpatientswithalveolarechinococcosis.JGastroenterol200540:426.
90. GargouriM,BenAmorN,BenChehidaF,etal.Percutaneoustreatmentofhydatidcysts(Echinococcus
granulosus).CardiovascInterventRadiol199013:169.
91. KhurooMS,DarMY,YattooGN,etal.Percutaneousdrainageversusalbendazoletherapyinhepatic
hydatidosis:aprospective,randomizedstudy.Gastroenterology1993104:1452.
92. FiliceC,DiPerriG,StrosselliM,etal.Parasitologicfindingsinpercutaneousdrainageofhumanhydatid
livercysts.JInfectDis1990161:1290.
93. GiorgioA,TarantinoL,FrancicaG,etal.Unilocularhydatidlivercysts:treatmentwithUSguided,double
percutaneousaspirationandalcoholinjection.Radiology1992184:705.
94. ClavelA,VareaM,DoizO,etal.Visualizationofhydatidelements:comparisonofseveraltechniques.J
ClinMicrobiol199937:1561.
95. BrunettiE,KernP,VuittonDA,WritingPanelfortheWHOIWGE.Expertconsensusforthediagnosis
andtreatmentofcysticandalveolarechinococcosisinhumans.ActaTrop2010114:1.
96. KernP,FroschP,HelbigM,etal.DiagnosisofEchinococcusmultilocularisinfectionbyreverse
transcriptionpolymerasechainreaction.Gastroenterology1995109:596.
97. RinaldiF,BrunettiE,NeumayrA,etal.Cysticechinococcosisoftheliver:Aprimerforhepatologists.
WorldJHepatol20146:293.
http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elaps

11/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

Topic5669Version12.0

http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elaps

12/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

GRAPHICS
Echinococcalcystoftheliver

Acomputedtomogramshowsamultilocularcystintheliverofapatientwith
hydatiddisease.
Reproducedwithpermissionfrom:SunT.ParasiticDisorders:Pathology,Diagnosis,and
Management,2ndedition.Baltimore:LippincottWilliams&Wilkins,1999.Copyright1999
LippincottWilliams&Wilkins.
Graphic58845Version4.0

http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elaps

13/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

Macroscopicappearanceofechinococcalcystsin
livertissue

Reproducedwithpermissionfrom:CraigPS,McManusDP,LightlowlersMW,et
al.Preventionandcontrolofcysticechinococcosis.LancetInfectDis2007
7:385.Copyright2007Elsevier.
Graphic74847Version3.0

http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elaps

14/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

WorldHealthOrganizationclassificationofcysticEchinococcus
(CE)andtreatmentstratifiedbycyststage
WHO
stage
CE1

CE2

Description

Stage

Unilocularunechoic
cysticlesionwith
doublelinesign

Active

Multiseptated,"rosette
like""honeycomb"cyst

Active

Preferred
treatment

Alternate
treatment

<5cm

Albendazole
alone

PAIR

>5cm

Albendazole+
PAIR

PAIR

Any

Albendazole+
eithermodified

Modified
catheterization

Size

catheterization
orsurgery
CE3a

Cystwithdetached
membranes(waterlily

Transitional

sign)

CE3b

Cystwithdaughter

Transitional

<5cm

Albendazole
alone

PAIR

>5cm

Albendazole+
PAIR

PAIR

Any

Albendazole+

Modified

eithermodified
catheterization
orsurgery

catheterization

cystsinsolidmatrix

CE4

Cystwithheterogenous

Inactive

Any

Observation

Inactive

Any

Observation

hypoechoic/hyperechoic
contentsnodaughter
cysts
CE5

Solidpluscalcifiedwall

Albendazoleisdosed10to15mg/kgperdayintwodivideddosestheusualdosefor
adultsis400mgtwicedaily.Durationoftherapyisdiscussedinthetext.
PAIR:Puncture,Aspiration,Injection,ReaspirationWHO:WorldHealthOrganization.
Datafrom:
1. JunghanssT,daSilvaAM,HortonJ,etal.Clinicalmanagementofcysticechinococcosis:state
oftheart,problems,andperspectives.AmJTropMedHyg200879:301.
2. BrunettiE,KernP,VuittonDA,WritingPanelfortheWHOIWGE.Expertconsensusforthe
diagnosisandtreatmentofcysticandalveolarechinococcosisinhumans.ActaTrop2010
114:1.
Graphic71806Version5.0

http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elaps

15/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

Ultrasonographicclassificationofcystsduetocysticechinococcus

(PanelCL)Consistsofunilocular,cysticlesion(s)(CL)withuniformanechoiccontent.Thecystwallis
clearlyvisiblelesionsareusuallyroundbutmaybeoval.Iftheselesionsarecausedbycysticechino
anearlystageofdevelopmenttheyareusuallynotfertile.Definitivediagnosiscannotbemadebyult
findingsalone.
(PanelCE1)Consistsofunilocular,simplecystwithuniformanechoiccontent.Thecystwallisvisible

areroundoroval.Cystmayexhibitfineechoesduetoshiftingofbroodcapsulescalledhydatidsand
flakesign").
(PanelCE2)Consistsofmultivesicular,multiseptatedcysts.Thecystwallisnormallyvisiblelesions

oroval.Septationsproduce"wheellike"structures.Thepresenceofdaughtercystsisindicatedbyro
orhoneycomblikestructures.Daughtercystsmaypartlyorcompletelyfilltheunilocularmothercyst.
(PanelCE3)Consistsofaunilocularcystwhichmaycontaindaughtercysts.Anechoiccontentwithde

oflaminatedmembranefromthecystwallmaybevisibleasfloatingmembraneoras"waterlilysign"
indicativeofwavymembranesfloatingontopofremainingcystfluid.Thecystformmaybelessroun
ofdecreasedintracysticpressure.Thecystwhichmaydegeneratefurtherormaygiverisetodaughte
(PanelCE4)Consistsofheterogenoushypoechoicorhyperechoicdegenerativecontentsnodaughter

present.A"ballofwool"signmaybeseenwhichisindicativeofdegeneratingmembranes.Mostcysts
typearenotfertile.Definitivediagnosiscannotbemadebyultrasoundfindingsalone.
(PanelCE5)Cystscharacterizedbyathickcalcifiedwallthatisarchshaped,producingaconeshape

Thedegreeofcalcificationvariesfrompartialtocomplete.Thesecystsarenotfertileinmostcase.D
diagnosiscannotbemadebyultrasoundfindingsalone.

WorldHealthOrganizationInformalWorkingGrouponEchinococcosis(WHOIWGE)standardizedclassificationofE
cysts.PAIR:Puncture,Aspiration,Injection,ReAspiration:AnoptionforthetreatmentofCysticEchinococcosis.
WHO/CDS/CSR/APH/2001.6.WorldHealthOrganization2001.Copyright2001.
Graphic87459Version1.0

http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elaps

16/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

Structureoftheechinococcalcyst

Graphic87460Version2.0

http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elaps

17/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

Sensitivityofserologictestsforechinococcosisatdifferentsites
Siteoflesion
Liver

Sensitivityofserologictests
IgGELISA:80to90percent
IgEELISA:82to92percent
Latexagglutination:65to75percent
Hemagglutination:80to90percent
Immunoblot(usingantigen5and/oraBrichfraction):80to90percent
Enzymelinkedimmunotransferblot:80percent

Lung

IgGELISA:60to85percent
IgEELISA:45to70percent
Latexagglutination:50to70percent
Hemagglutination:50to70percent
Immunoblot(usingantigen5and/oraBrichfraction):55to70percent
Enzymelinkedimmunotransferblot:55percent

Ig:immunoglobulinELISA:enzymelinkedimmunosorbentassay.
Graphic66506Version2.0

http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elaps

18/19

14/2/2015

Clinicalmanifestationsanddiagnosisofechinococcosis

Disclosures
Disclosures:PedroLMoro,MD,MPHNothingtodisclose.PeterFWeller,MD,FACP
Grant/Research/ClinicalTrialSupport:NIH[EGPA(Mepolizumab)].Consultant/AdvisoryBoards:GSK
[EGPA(Mepolizumab)].ElinorLBaron,MD,DTMHEmployeeofUpToDate,Inc.
Contributordisclosuresarereviewedforconflictsofinterestbytheeditorialgroup.Whenfound,these
areaddressedbyvettingthroughamultilevelreviewprocess,andthroughrequirementsfor
referencestobeprovidedtosupportthecontent.Appropriatelyreferencedcontentisrequiredofall
authorsandmustconformtoUpToDatestandardsofevidence.
Conflictofinterestpolicy

http://www.uptodate.com.ezproxy.uniandes.edu.co:8080/contents/clinicalmanifestationsanddiagnosisofechinococcosis?topicKey=ID%2F5669&elaps

19/19

Вам также может понравиться